{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T18:26:00Z","timestamp":1783189560039,"version":"3.54.6"},"reference-count":31,"publisher":"The Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6,1]]},"DOI":"10.1210\/jc.2013-4159","type":"journal-article","created":{"date-parts":[[2014,3,10]],"date-time":"2014-03-10T11:10:02Z","timestamp":1394449802000},"page":"2030-2037","source":"Crossref","is-referenced-by-count":122,"title":["Growth Hormone Exposure as a Risk Factor for the Development of Subsequent Neoplasms of the Central Nervous System: A Report From the Childhood Cancer Survivor Study"],"prefix":"10.1210","volume":"99","author":[{"given":"Briana C.","family":"Patterson","sequence":"first","affiliation":[{"name":"Department of Pediatrics (B.C.P., A.Mer., L.R.M.) Emory University\/Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Atlanta, Georgia 30322;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences (Y.C., Y.Y.), University of Alberta, Edmonton, Alberta, Canada T6G 1C9;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"Sklar","sequence":"additional","affiliation":[{"name":"Department of Pediatrics (C.A.S.), Memorial Sloan-Kettering Cancer Center, New York, New York 10065;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Neglia","sequence":"additional","affiliation":[{"name":"Department of Pediatrics (J.N.), University of Minnesota Medical School, Minneapolis, Minnesota 55454;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Yasui","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences (Y.C., Y.Y.), University of Alberta, Edmonton, Alberta, Canada T6G 1C9;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Mertens","sequence":"additional","affiliation":[{"name":"Department of Pediatrics (B.C.P., A.Mer., L.R.M.) Emory University\/Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Atlanta, Georgia 30322;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory T.","family":"Armstrong","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Cancer Control (G.T.A., L.L.R.), St Jude Children's Research Hospital, Memphis, Tennessee 38105;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Meadows","sequence":"additional","affiliation":[{"name":"Division of Oncology (A.Mea.), The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn","family":"Stovall","sequence":"additional","affiliation":[{"name":"Department of Radiation Physics (M.S.), The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie L.","family":"Robison","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Cancer Control (G.T.A., L.L.R.), St Jude Children's Research Hospital, Memphis, Tennessee 38105;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian R.","family":"Meacham","sequence":"additional","affiliation":[{"name":"Department of Pediatrics (B.C.P., A.Mer., L.R.M.) Emory University\/Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Atlanta, Georgia 30322;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"issue":"3","key":"key\n\t\t\t\t2019041113544151700_B1","first-page":"663","article-title":"Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study","volume":"97","author":"Gurney","year":"2003","journal-title":"Cancer"},{"issue":"7","key":"key\n\t\t\t\t2019041113544151700_B2","first-page":"616","article-title":"Prevalence and risk factors of radiation-induced growth hormone deficiency in childhood cancer survivors: a systematic review","volume":"35","author":"Mulder","year":"2009","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"key\n\t\t\t\t2019041113544151700_B3","first-page":"1666","article-title":"Cranial irradiation and growth hormone neurosecretory dysfunction: a critical appraisal","volume":"92","author":"Darzy","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113544151700_B4","first-page":"S30","article-title":"Pathophysiology of radiation-induced growth hormone deficiency: efficacy and safety of GH replacement","volume":"16","author":"Darzy","year":"2006","journal-title":"Growth Horm IGF Res"},{"issue":"4","key":"key\n\t\t\t\t2019041113544151700_B5","first-page":"565","article-title":"Incidence of second neoplasm in childhood cancer survivors treated with GH: an analysis of GeNeSIS and HypoCCS","volume":"168","author":"Woodmansee","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"key\n\t\t\t\t2019041113544151700_B6","first-page":"115","article-title":"Does growth hormone cause cancer?","volume":"64","author":"Jenkins","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"key\n\t\t\t\t2019041113544151700_B7","first-page":"915","article-title":"Insulin and insulin-like growth factor signalling in neoplasia","volume":"8","author":"Pollak","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"key\n\t\t\t\t2019041113544151700_B8","first-page":"480","article-title":"Growth hormone replacement therapy in children with medulloblastoma: use and effect on tumor control","volume":"19","author":"Packer","year":"2001","journal-title":"J Clin Oncol"},{"issue":"7","key":"key\n\t\t\t\t2019041113544151700_B9","first-page":"3136","article-title":"Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study","volume":"87","author":"Sklar","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"key\n\t\t\t\t2019041113544151700_B10","first-page":"3494","article-title":"Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor","volume":"91","author":"Ergun-Longmire","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"key\n\t\t\t\t2019041113544151700_B11","first-page":"1284","article-title":"Recurrence of brain tumours in patients treated with growth hormone: analysis of KIGS (Pfizer International Growth Database)","volume":"95","author":"Darendeliler","year":"2006","journal-title":"Acta Paediatr"},{"issue":"9","key":"key\n\t\t\t\t2019041113544151700_B12","first-page":"2756","article-title":"Long-term safety of growth hormone replacement after CNS irradiation","volume":"96","author":"Mackenzie","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"key\n\t\t\t\t2019041113544151700_B13","first-page":"698","article-title":"Adult growth hormone replacement therapy and neuroimaging surveillance in brain tumour survivors","volume":"62","author":"Jostel","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"key\n\t\t\t\t2019041113544151700_B14","first-page":"229","article-title":"Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project","volume":"38","author":"Robison","year":"2002","journal-title":"Med Pediatr Oncol"},{"issue":"14","key":"key\n\t\t\t\t2019041113544151700_B15","first-page":"2308","article-title":"The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research","volume":"27","author":"Robison","year":"2009","journal-title":"J Clin Oncol"},{"issue":"14","key":"key\n\t\t\t\t2019041113544151700_B16","first-page":"2319","article-title":"Pediatric cancer survivorship research: experience of the Childhood Cancer Survivor Study","volume":"27","author":"Leisenring","year":"2009","journal-title":"J Clin Oncol"},{"issue":"21","key":"key\n\t\t\t\t2019041113544151700_B17","first-page":"1528","article-title":"New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study","volume":"98","author":"Neglia","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"key\n\t\t\t\t2019041113544151700_B18","first-page":"285","article-title":"Risk of subsequent cancer following a primary CNS tumor","volume":"112","author":"Strodtbeck","year":"2013","journal-title":"J Neurooncol"},{"issue":"1","key":"key\n\t\t\t\t2019041113544151700_B19","first-page":"93","article-title":"Growth hormone receptor expression and function in meningiomas: effect of a specific receptor antagonist","volume":"91","author":"Friend","year":"1999","journal-title":"J Neurosurg"},{"issue":"4","key":"key\n\t\t\t\t2019041113544151700_B20","first-page":"538","article-title":"Characterization of insulin-like growth factor I and epidermal growth factor receptors in meningioma","volume":"71","author":"Kurihara","year":"1989","journal-title":"J Neurosurg"},{"issue":"3","key":"key\n\t\t\t\t2019041113544151700_B21","first-page":"487","article-title":"Antitumor activity of the growth hormone receptor antagonist pegvisomant against human meningiomas in nude mice","volume":"94","author":"McCutcheon","year":"2001","journal-title":"J Neurosurg"},{"issue":"3","key":"key\n\t\t\t\t2019041113544151700_B22","first-page":"502","article-title":"Effect of suramin on 125I-insulin-like growth factor-I binding to human meningiomas and on proliferation of meningioma cells","volume":"80","author":"Tsutsumi","year":"1994","journal-title":"J Neurosurg"},{"issue":"4","key":"key\n\t\t\t\t2019041113544151700_B23","first-page":"600","article-title":"Inhibition of proliferation of human cerebral meningioma cells by suramin: effects on cell growth, cell cycle phases, extracellular growth factors, and PDGF-BB autocrine growth loop","volume":"82","author":"Schrell","year":"1995","journal-title":"J Neurosurg"},{"issue":"2","key":"key\n\t\t\t\t2019041113544151700_B24","first-page":"84","article-title":"Growth hormone and insulin-like growth factor-I: effects on the growth of glioma cell lines","volume":"11","author":"Friend","year":"2001","journal-title":"Growth Horm IGF Res"},{"issue":"6","key":"key\n\t\t\t\t2019041113544151700_B25","first-page":"335","article-title":"Growth hormone enhances natural killer cell activity against glioma","volume":"72","author":"Shimizu","year":"2005","journal-title":"J Nippon Med Sch"},{"issue":"10","key":"key\n\t\t\t\t2019041113544151700_B26","first-page":"2562","article-title":"Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study","volume":"19","author":"Michaud","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"12","key":"key\n\t\t\t\t2019041113544151700_B27","first-page":"2149","article-title":"Exogenous sex hormone use and risk of meningioma: a population-based case-control study in Finland","volume":"21","author":"Korhonen","year":"2010","journal-title":"Cancer Causes Control"},{"issue":"7","key":"key\n\t\t\t\t2019041113544151700_B28","first-page":"1692","article-title":"Hormone replacement therapy and incidence of central nervous system tumours in the Million Women Study","volume":"127","author":"Benson","year":"2010","journal-title":"Int J Cancer"},{"issue":"5","key":"key\n\t\t\t\t2019041113544151700_B29","first-page":"1174","article-title":"Therapeutic significance of estrogen receptor \u03b2 agonists in gliomas","volume":"11","author":"Sareddy","year":"2012","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"key\n\t\t\t\t2019041113544151700_B30","first-page":"336","article-title":"Study of effectiveness of mifepristone for glioma cell line growth suppression","volume":"26","author":"Ramaswamy","year":"2012","journal-title":"Br J Neurosurg"},{"issue":"1","key":"key\n\t\t\t\t2019041113544151700_B31","first-page":"61","article-title":"Health care of young adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study","volume":"2","author":"Oeffinger","year":"2004","journal-title":"Ann Fam Med"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/99\/6\/2030\/9048206\/jcem2030.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T04:32:31Z","timestamp":1555043551000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/99\/6\/2030\/2537621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,1]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2013-4159","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,1]]}}}